eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
2/2011
vol. 15
 
Share:
Share:
more
 
 
abstract:
Case report

Carcinoma of the urachus and the role of PET-CT in disease recurrence – case report

Marta Biedka
,
Ewa Ziółkowska
,
Bogdan Małkowski
,
Roman Makarewicz

Contemporary Oncology (2011) vol. 15; 2 (111–114)
Online publish date: 2011/04/29
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Urachal carcinoma is a rare cancer that accounts for 0.5%-2% of all bladder cancers. These tumours are commonly seen in patients 40-70 years of age, two-thirds of whom are men. Most urachal cancers are adenocarcinomas but other histological subtypes are described. Patients with urachal cancer may have no symptoms until the late stage. The most common clinical signs are suprapubic mass, haematuria and dysuria. The recommended treatment is primarily surgical, with extended partial cystectomy, en bloc excision of the urachal mass, urachal tract and umbilicus, and pelvic lymph node dissection. While some have advocated radical cystectomy as definitive therapy, this procedure can usually be reserved for larger tumours. Radiation and che­motherapy are ineffective against urachal carcinoma. The aim of this article is to present a patient with urachal carcinoma and describe the treatment, including the special role of PET-CT.
keywords:

carcinoma, urachus, PET-CT

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe